About Us

KAROLINSKA INSTITUTET PRESS OFFICE Phone opening hours: weekdays 08-20, weekends 09-17, local time. Emails are checked during business hours. Karolinska Institutet – a medical university. More about us on


  • Press Office
    +46 8 524 860 77
  • Anna von Corswant

    Chief Press Officer

    +46-(0)8-524 866 13
    +46 (0)73-980 79 92
  • Felicia Lindberg

    Press Officer

    +46 (0) 8-524 866 06
    +46 (0) 73-983 20 81
  • Camilla Magnusson

    Director of Communications

    +46 8 524 863 45
    +46 70 748 55 89
  • Quotes

    We need to ask about aggressive behaviour towards others when we assess and treat self-harming individuals, but we also need to ask about self-harm when we assess and treat aggressive individuals
    Hanna Sahlin
    We now have a simple tool for identifying and sorting the cells, which benefits future stem cell research and basic research on early embryonic development
    Fredrik Lanner
    Although this might seem simple and obvious, the impact of the hydraulic force on the heart’s filling pattern has been overlooked
    Martin Ugander
    The diabetes trend is largely driven by lifestyle factors, so to reduce your risk of diabetes you should not use tobacco, avoid being overweight and be physically active.
    Sofia Carlsson, PhD, Senior lecturer at Karolinska Institutet
    If we can introduce a more accurate way of testing for prostate cancer, we’ll spare patients unnecessary suffering and save resources for society.
    Professor Henrik Grönberg, Karolinska Institutet
    The possibility of preventing or slowing down the spread of cancer cells via the lymphatic system is an attractive one, as it could reduce the risk of metastasis to other organs.
    Jonas Fuxe, Associate Professor, Karolinska Institutet
    The study will form the basis of new guidelines from the WHO, which will recommend that midwives be allowed to handle the treatment of incomplete abortions.
    Kristina Gemzell Danielsson, MD, PhD, Professor
    Since bariatric surgery followed by pregnancy has both positive and negative effects, these women, when expecting, should be regarded as risk pregnancies.
    Dr. Kari Johansson, Karolinska Institutet
    We have created a much more detailed map of the cells of the brain that describes each cell type in detail and shows which genes are active in it.
    Jens Hjerling-Leffler, principal investigator at Karolinska Institutet
    What’s particularly exciting is that we’ve managed to translate laboratory findings into clinical application.
    Professor Per Svenningsson, Karolinska Institutet
    It's possible that this work opens up a new pharmacological principle in the treatment of depression.
    Jorge Ruas, P.I.
    Our current view of both the occurrence and treatment of obesity is far too narrow, since we talk almost exclusively about diet and exercise.
    Erik Hemmingsson, researcher Karolinska Institutet
    De Lange is a frontrunner in the field of telomeres, so we are very pleased to have her give this year's Nicholson Lecture
    Professor Maria Masucci, academic host of the lecture at Karolinska Institutet
    We believe that these very promising findings represent major advances towards the clinical translation of tissue engineered esophagi.
    Dr Paolo Macchiarini
    That existing anticancer agents hit the MTH1 shows that the concept really works. Now that we understand the mechanism, we can develop very selective inhibitors.
    Professor Thomas Helleday, Karolinska Institutet and SciLifeLab
    This is an entirely new mechanism for cancer treatment. A possible medicine based on this principle would therefore attack the glioblastoma in an entirely new way.
    Professor Patrik Ernfors
    As many as nearly 30 per cent of the adolescents clustered in the 'invisible' group that had a high level of psychopathological symptoms.
    Vladimir Carli, researcher at NASP
    It has not previously been observed that the inhibition of MYC affects tumour cells in this way
    Professor Marie Arsenian Henriksson
    Oligonucleotide-based drugs are already available, and it’s very possible that our method could be used to produce purer and cheaper versions of these drugs.
    Björn Högberg, Assistant Professor at Karolinska Institutet
    Pick a time period -
    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top